Avax One Technology Ltd. (AVX) Q1 2026 Earnings Call Transcript
Avax One Technology Ltd. (AVX) Q1 2026 Earnings Call Transcript
seekingalpha.com
SANA(SANA)
SANA
Next earnings: Aug 10, 2026
Signal
Bearish Setup2↓
PRICE
Prev Close
3.14
Open
3.05
Day Range2.96 – 3.11
2.96
3.11
52W Range1.63 – 6.55
1.63
6.55
29% of range
VOLUME & SIZE
Avg Volume
3.3M
FUNDAMENTALS
P/E Ratio
-3.3x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
2.24
High vol
Performance
1D
-1.88%5D
-8.99%1M
-9.77%3M
-18.44%6M
-21.30%YTD↓
-22.85%1Y↑
+76.40%Best: 1Y (+76.40%)Worst: YTD (-22.85%)
Quick Read
Trend—Insufficient MA data
Momentum
BEARISH
thin 0% gross marginValuation
FAIR
P/E not availableHealth
WEAK
CR 1.3 · FCF negativeBearish
Key MetricsTTM
Market Cap$854.36M
Revenue TTM$0.00
Net Income TTM-$241.99M
Free Cash Flow-$133.64M
Gross Margin0.0%
Net Margin0.0%
Operating Margin0.0%
Return on Equity-161.9%
Return on Assets-64.8%
Debt / Equity0.63
Current Ratio1.29
EPS TTM$-0.87
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
1 strong2 watch3 concern
30/100Liquidity
1.29Watch
Leverage
0.63Strong
Coverage
0.0xConcern
ROE
-161.9%Concern
ROIC
-78.6%Concern
Cash
$72MWatch
ANALYST COVERAGE11 analysts
BUY
▲ +128.0%upside to target
L $7.00
Med $7.00consensus
H $12.00Stock Health
Composite Score
2 of 5 signals bullish
4/10
Technicals
●
✗RSI RangeRSI 43 — Bearish momentum
Volume
●
✗Volume FlowDistribution — institutional selling
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
~LiquidityCurrent Ratio 1.29
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentAug 31, 2026
In 107 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendDeath Cross · 50D trails 200D by 15.8%
-6.2% vs SMA 50 · -21.1% vs SMA 200
Momentum
RSI42.6Momentum fading
MACD-0.03Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$6.55+113.4%
EMA 200
$3.64+18.5%
EMA 50
$3.44+12.0%
Current
$3.07
52W Low
$1.63-47.1%
52-Week RangeMid-range
$1.6329th %ile$6.55
Squeeze SetupVolume-based
Distribution PressureHeavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.
20-Day Money Flow
Acc days:1
Dist days:6
Edge:+5 dist
Volume Context
Avg Vol (50D)3.7M
Recent Vol (5D)
7.5M+105%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 6 analysts
Analyst revisions:EPS↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $0 | — | -$0.86 | — | ±3% | High5 |
FY2026(current) | $0 | — | -$0.63 | — | ±13% | High5 |
FY2027 | $7.0M $7.0M–$7.0M | — | -$0.60 | — | ±18% | High6 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistorySANA
Last 8Q
+2.8%avg beat
Beat 6 of 8 quartersMissed 2↑ Estimates rising-19%
Q3'24
+4%
Q4'24
+8%
Q1'25
+9%
Q2'25
+20%
Q3'25
+17%
Q4'25
-23%
Q1'26
+7%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced heightAnalyst Activity
All ratings →No recent activity
JMP SecuritiesPerform
Nov 5
DOWNGRADE
H.C. WainwrightBuy
Jan 16
UPGRADE
Insider Activity
SEC Filings →0 Buys/6 SellsNet Selling
Fmr Llc10 Percent Own…
$611K
Jan 8
SELL
Fmr Llc10 Percent Own…
$163K
Jan 8
SELL
Fmr Llc10 Percent Own…
$1.1M
Jan 8
SELL
Fmr Llc10 Percent Own…
$7K
Jan 8
SELL
Mulligan RichardDir
$613K
Sep 24
SELL
Mulligan RichardDir
$583K
Sep 25
SELL
Financials
INSTITUTIONAL OWNERSHIP
1
BlackRock, Inc.
14.2M▲2
BAILLIE GIFFORD & CO
6.6M—3
Marex Group plc
4.0M▲4
Alphabet Inc.
2.8M—5
NORTHERN TRUST CORP
1.5M▲6
RENAISSANCE TECHNOLOGIES LLC
1.5M▼7
UBS Group AG
1.4M▲8
VANGUARD FIDUCIARY TRUST CO
1.1M▲News & Activity
SANA News
19 articles · 4h ago
EUFN: European Financials Remain Attractively Valued Ahead Of Potential Rate Hikes
seekingalpha.com
U.S. Global Investors' Frank Holmes on why travel stocks look undervalued - ICYMI
proactiveinvestors.com
Kyivstar Group Ltd. (KYIV) Q1 2026 Earnings Call Transcript
seekingalpha.com
BMW's Wild Vision K 18 Concept Looks Ready for Blade Runner
youtube.com
BlackRock weighs multibillion-dollar investment in SpaceX IPO, the Information reports
reuters.com
Orbit Garant Drilling Q3 Earnings Call Highlights
marketbeat.com
Onex Q1 Earnings Call Highlights
marketbeat.com
Pollard Banknote Q1 Earnings Call Highlights
marketbeat.com
Pet Valu Q1 Earnings Call Highlights
marketbeat.com
Peyto Exploration & Development Q1 Earnings Call Highlights
marketbeat.com
Parex Resources Q1 Earnings Call Highlights
marketbeat.com
Quebecor Q1 Earnings Call Highlights
marketbeat.com
Quarterhill Q1 Earnings Call Highlights
marketbeat.com
Gen Z shoppers helping revive America’s malls with push for in-person experiences
foxbusiness.com
Studies Highlight Advances in Kidney Stone Prevention and Anesthesia Free Stone Removal
globenewswire.com
Kolter Urban Selects FirstService Residential to Manage Art House St. Petersburg
prnewswire.com
KinderCare Learning Companies, Inc. (KLC) Q1 2026 Earnings Call Transcript
seekingalpha.com
Seagate and Western Digital: AI Storage Demand Is Now Showing Up in Pricing Power
247wallst.com
About
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly available to patients. Sana is more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Industry
Research and Development in Biotechnology
Website
Dhavalkumar D. PatelExecutive Vice President & Chief Scientific Officer
Steven D. HarrPresident, Chief Executive Officer & Director
Brian D. PiperExecutive Vice President & Chief Financial Officer
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
SANA◀ | $3.07 | -1.88% | $854M | — | — | — | 1500 |
| $66.13 | -5.07% | $13.0B | — | +12626.1% | -14525.8% | 1500 | |
| $94.92 | -3.79% | $12.6B | — | +3288.2% | -4239.0% | 1500 | |
| $523.69 | -3.00% | $12.1B | — | +43205.3% | -3008.0% | 1500 | |
| $227.72 | -1.30% | $11.7B | — | +6554.5% | -2868.8% | 1500 | |
| $57.90 | -0.86% | $11.2B | 50.3 | +1459.3% | 147.7% | 1500 | |
| $76.67 | -3.79% | $10.8B | — | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -2.81% | — | 50.3 | +398824.8% | -4085.6% | 1500 |